Prognosis
Pfizer to Launch Final Study of Covid Shot in Kids Under 12
- Study to include 4,500 participants across more than 90 sites
- Lower doses of the vaccine formulated for younger children
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know
Pfizer Inc. and BioNTech SE’s vaccine will be tested in children less than 12 years old in a late-stage study seeking to extend Covid-19 protection across the entire range of ages.